Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000291859 | SCV000340534 | pathogenic | not provided | 2016-03-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001228980 | SCV001401410 | pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-10-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg72*) in the MCCC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCCC2 are known to be pathogenic (PMID: 11181649, 22642865). This variant is present in population databases (rs147903984, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with 3-methylcrotonyl-CoA carboxylase deficiency (PMID: 16010683, 22150417). ClinVar contains an entry for this variant (Variation ID: 286933). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000291859 | SCV004035598 | pathogenic | not provided | 2023-09-12 | criteria provided, single submitter | clinical testing | Identified in the heterozygous state with a second MCCC2 variant in infants identified by newborn screening, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (Dantas et al., 2005; Forsyth et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 27033733, 16010683, 32778825) |
Baylor Genetics | RCV001228980 | SCV004194338 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-03-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001228980 | SCV002084283 | pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2020-04-10 | no assertion criteria provided | clinical testing |